# Clinical and Histopathologic Characteristics of BAP1 Mutations

> **NCT01773655** · — · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 196 (actual)

## Conditions studied

- Malignant Pleural Mesothelioma (MPM)
- Choroidal Nevus
- Primary Uveal Melanoma (UM)
- Metastatic Uveal Melanoma (UM)
- Renal Cell Carcinoma
- Cholangiocarcinoma

## Interventions

- **OTHER:** tumor specimens

## Key facts

- **NCT ID:** NCT01773655
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2020-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01773655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01773655, "Clinical and Histopathologic Characteristics of BAP1 Mutations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01773655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*